SLC2A13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.651800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.185200E-01
Normal-vs-Stage2
8.400000E-01
Normal-vs-Stage3
3.120400E-01
Normal-vs-Stage4
8.908400E-01
Stage1-vs-Stage2
9.286000E-02
Stage1-vs-Stage3
8.047700E-02
Stage1-vs-Stage4
3.644600E-01
Stage2-vs-Stage3
1.861170E-01
Stage2-vs-Stage4
9.336400E-01
Stage3-vs-Stage4
5.146500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.589200E-01
Normal-vs-AfricanAmerican
6.794600E-01
Normal-vs-Asian
7.258000E-01
Caucasian-vs-AfricanAmerican
9.925800E-01
Caucasian-vs-Asian
6.759900E-02
AfricanAmerican-vs-Asian
2.637000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.132400E-01
Normal-vs-Female
7.966600E-01
Male-vs-Female
9.577200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.652000E-01
Normal-vs-Age(41-60Yrs)
5.745200E-01
Normal-vs-Age(61-80Yrs)
8.064400E-01
Normal-vs-Age(81-100Yrs)
7.652200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.398800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.222600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.238800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.815400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.260200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.818420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.958800E-01
Normal-vs-Daily Drinker
7.904400E-01
Normal-vs-Weekly Drinker
8.781200E-01
Normal-vs-Occasional Drinker
6.796400E-01
Normal-vs-Social Drinker
5.103800E-01
Non Drinker-vs-Daily Drinker
9.934800E-01
Non Drinker-vs-Weekly Drinker
7.764000E-01
Non Drinker-vs-Occasional Drinker
2.395800E-01
Non Drinker-vs-Social Drinker
8.388000E-02
Daily Drinker-vs-Weekly Drinker
8.303200E-01
Daily Drinker-vs-Occasional Drinker
2.455000E-01
Daily Drinker-vs-Social Drinker
9.515800E-02
Weekly Drinker-vs-Occasional Drinker
2.783400E-01
Weekly Drinker-vs-Social Drinker
1.297980E-01
Occasional Drinker-vs-Social Drinker
8.503000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.610800E-01
Normal-vs-Grade 2
1.465420E-01
Normal-vs-Grade 3
8.413800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.282370E-01
Grade 1-vs-Grade 3
9.502300E-02
Grade 1-vs-Grade 4
3.610800E-01
Grade 2-vs-Grade 3
5.834000E-01
Grade 2-vs-Grade 4
1.465420E-01
Grade 3-vs-Grade 4
8.413800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.967400E-01
Normal-vs-NonDiabetic
8.369000E-01
Diabetic-vs-NonDiabetic
3.096600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.042200E-01
Normal-vs-NoPancreatitis
8.255200E-01
Pancreatitis-vs-NoPancreatitis
4.515500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.844000E-01
Normal-vs-N1
8.165000E-01
N0-vs-N1
2.191800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.705400E-01
Normal-vs-TP53-NonMutant
5.041000E-01
TP53-Mutant-vs-TP53-NonMutant
1.149920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
